tiprankstipranks
Advertisement
Advertisement
Relay Therapeutics: Buy Rating on Undervalued Zovegalisib Franchise with Multi‑Billion Peak Sales Potential in Breast Cancer and Vascular Anomalies
PremiumRatingsRelay Therapeutics: Buy Rating on Undervalued Zovegalisib Franchise with Multi‑Billion Peak Sales Potential in Breast Cancer and Vascular Anomalies
24d ago
Relay Therapeutics Targets NRAS Cancers With New First-in-Human Trial
Premium
Company Announcements
Relay Therapeutics Targets NRAS Cancers With New First-in-Human Trial
29d ago
Relay Therapeutics Expands Authorized Shares at 2026 Meeting
Premium
Company Announcements
Relay Therapeutics Expands Authorized Shares at 2026 Meeting
2M ago
Relay Therapeutics 22.9M share Secondary priced at $12.00
PremiumThe FlyRelay Therapeutics 22.9M share Secondary priced at $12.00
2M ago
Relay Therapeutics price target raised to $21 from $19 at Citizens
Premium
The Fly
Relay Therapeutics price target raised to $21 from $19 at Citizens
2M ago
Relay Therapeutics price target raised to $27 from $21 at Barclays
Premium
The Fly
Relay Therapeutics price target raised to $27 from $21 at Barclays
2M ago
Relay Therapeutics rises 8.6%
PremiumThe FlyRelay Therapeutics rises 8.6%
2M ago
Midday Fly By: Home Depot reports Q1 beat, Blackstone and Google form cloud JV
Premium
The Fly
Midday Fly By: Home Depot reports Q1 beat, Blackstone and Google form cloud JV
2M ago
Relay Therapeutics price target raised to $26 from $23 at Raymond James
Premium
The Fly
Relay Therapeutics price target raised to $26 from $23 at Raymond James
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100